One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Accesshttps://doi.org/10.1182/blood.v130.suppl_1.579.579
Copy DOI Journal: Blood |  Publication Date: Jun 25, 2021 |
Affiliation: The University of Texas MD Anderson Cancer Center, Moffitt Cancer Center, Washington University in St. Louis, University of Miami Health System, University of Rochester, Stanford University, Dana-Farber Cancer Institute, Albert Einstein College of Medicine, Vanderbilt University Medical Center, City Of Hope National Medical Center, Queen's University, Cliniques Universitaires Saint-Luc, University of Iowa, Kite (United States)A Comparison of One Year Outcomes in ZUMA-1 (axicabtagene ciloleucel) and SCHOLAR-1 in Patients with Refractory, Aggressive Non-Hodgkinlymphoma (NHL)
Sign-in/Register to access full text options 
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
